AMBER SEELER: Open Payments
NPI 1629644547 · VICTOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 53 payments from 13 companies in 2025. Trend: 2023 $4,056 · 2024 $3,431 · 2025 $945
Food & beverage: $945
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $220 |
| Novo Nordisk Inc | 6 | $130 |
| Phathom Pharmaceuticals, Inc. | 9 | $95 |
| Dexcom, Inc. | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Lilly USA, LLC | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| SCILEX PHARMACEUTICALS INC. | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| PFIZER INC. | 2 | $41 |
Products named: VRAYLAR, VOQUEZNA, Dexcom G6 Transmitter, Ozempic, LEQVIO, GLOPERBA, FARXIGA, QULIPTA.
Industry payments across NY — which companies pay providers there.
